Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
2 Resilient Growth Stocks to Buy and Hold Forever
10:15am, Saturday, 18'th Feb 2023
These two "pandemic stocks" are still great investments.
Three-Stock Lunch: DE, AN and MRNA
03:19pm, Friday, 17'th Feb 2023
Diamond Hill Capital Management's Heather Brilliant joins CNBC's reporter panel on 'Power Lunch' to discuss Deere, AutoNation, and Moderna, three stocks making moves after earnings results.
Moderna stock declines on mixed flu vaccine trial results
12:12pm, Friday, 17'th Feb 2023
Yahoo Finance's Julie Hyman, Brian Sozzi, and Brad Smith discuss why Moderna stock is down on Friday.
Moderna's stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID.
10:51am, Friday, 17'th Feb 2023
Moderna Inc.'s stock slid 5% Friday after the COVID vaccine maker said a trial of a flu-vaccine candidate that uses the same technology as its COVID shot had mixed results and failed to meet one of it
Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees
10:47am, Friday, 17'th Feb 2023
Moderna stock toppled Friday on mixed results for its flu shot — a rival to experimental vaccines from BioNTech, CureVac and Sanofi. The post Moderna Hypes 'Important Step' In Flu Shot Results, But
Why Is Moderna (MRNA) Stock Down 5% Today?
09:42am, Friday, 17'th Feb 2023
Moderna (NASDAQ: MRNA ) stock fell 5% overnight after receiving mixed results on a large-scale study of its seasonal flu vaccine. The vaccine uses the same messenger RNA technology as Moderna's Covid-
Moderna shares fall on mixed flu vaccine study results
08:52am, Friday, 17'th Feb 2023
Moderna Therapeutics Inc (NASDAQ:MRNA) shares have fallen more than 5% in pre-market trading after the biotechnology company reported mixed results from a study of its experimental influenza (flu) vac
Moderna's mRNA flu vaccine met study goals for influenza A, but not B
05:15pm, Thursday, 16'th Feb 2023
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Moderna's flu vaccine trial results.
Moderna stock falls 5% after flu vaccine study results
04:16pm, Thursday, 16'th Feb 2023
Moderna Inc. shares dove more than 5% in after-hours trading Thursday, after the company announced that a study into a flu vaccine candidate failed to reach one of its goals.
A Bull Market Is Coming. To Prepare, Take Warren Buffett's Advice.
02:00pm, Thursday, 16'th Feb 2023
Quality and price are two key elements to keep in mind.
Moderna's COVID vaccine will remain free for all Americans in coup for Bernie Sanders
10:41am, Thursday, 16'th Feb 2023
Moderna Inc. will keep its COVID-19 vaccines available and free of charge for all people in the U.S. after the public-health emergency ends, the company said late Wednesday.
Moderna and Cirrus Logic Are Balance Sheet Powerhouses
10:19am, Thursday, 16'th Feb 2023
On a hilltop in your town live two people. Joseph has an income of $400,000 a year but little savings.
The 10 Biggest Companies Reporting Earnings in the Fourth Week of February 2023
10:51pm, Wednesday, 15'th Feb 2023
Companies with a strong earnings growth rate are usually on traders' radars. Thus, it is important to keep track of stocks that are due to announce their earnings report card.
Moderna promises to keep COVID vaccine free
04:07pm, Wednesday, 15'th Feb 2023
Moderna Inc. MRNA, +0.95% said Tuesday it will keep its COVID-19 vaccines available and free for all people in the U.S. after the public-health emergency ends. For uninsured or underinsured people, Mo
